Millennium Management
RPTX

Millennium Management’s Repare Therapeutics RPTX Stock Holding History

Millennium Management’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-407,858
Closed -$567K – 6401
2025
Q2 		$567K Buy
407,858
+256,622
+170% +$335K ﹤0.01% 4819
2025
Q1 		$149K Sell
151,236
-19,723
-12% -$23.8K ﹤0.01% 5365
2024
Q4 		$224K Buy
170,959
+67,638
+65% +$201K ﹤0.01% 5243
2024
Q3 		$355K Sell
103,321
-146,154
-59% -$481K ﹤0.01% 5093
2024
Q2 		$823K Buy
249,475
+80,610
+48% +$287K ﹤0.01% 4239
2024
Q1 		$795K Sell
168,865
-13,232
-7% -$84.8K ﹤0.01% 4495
2023
Q4 		$1.33M Buy
182,097
+159,410
+703% +$892K ﹤0.01% 3932
2023
Q3 		$274K Sell
22,687
-106,461
-82% -$1.1M ﹤0.01% 4984
2023
Q2 		$1.37M Sell
129,148
-300,722
-70% -$3.1M ﹤0.01% 3787
2023
Q1 		$4.23M Sell
429,870
-175,417
-29% -$2.01M ﹤0.01% 2758
2022
Q4 		$8.9M Buy
605,287
+357,966
+145% +$5.35M ﹤0.01% 2259
2022
Q3 		$3M Buy
247,321
+163,126
+194% +$2.1M ﹤0.01% 3392
2022
Q2 		$1.18M Sell
84,195
-135,959
-62% -$1.6M ﹤0.01% 4220
2022
Q1 		$3.13M Sell
220,154
-110,672
-33% -$1.64M ﹤0.01% 3451
2021
Q4 		$6.98M Buy
330,826
+159,365
+93% +$3.75M ﹤0.01% 2554
2021
Q3 		$4.5M Buy
171,461
+148,876
+659% +$4.81M ﹤0.01% 2973
2021
Q2 		$704K Buy
+22,585
New +$740K ﹤0.01% 4981
2021
Q1 		– Sell
-95,018
Closed -$3.26M – 6435
2020
Q4 		$3.26M Sell
95,018
-94,627
-50% -$2.83M ﹤0.01% 2839
2020
Q3 		$5.83K Sell
189,645
-33,599
-15% -$890K 0.01% 1692
2020
Q2 		$6.92M Buy
+223,244
New +$7.17M 0.01% 1487

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return

Millennium Management's RPTX Position: Q3 2025 in Review

Millennium Management sold out of Repare Therapeutics (RPTX) in Q3 2025, closing a stake of 407,858 shares — an estimated $567K sold.

Millennium Management first reported a position in RPTX in Q2 2020 and held it in 20 quarters. The position peaked at $8.9M in Q4 2022. 45 funds tracked by Wall St. Rank hold RPTX as of Q3 2025.

  • Millennium Management reported no remaining Repare Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Millennium Management sold 407,858 Repare Therapeutics shares in Q3 2025, an estimated $567K.
  • Millennium Management first reported a position in Repare Therapeutics in Q2 2020 and held it in 20 quarters.
  • Millennium Management's Repare Therapeutics position peaked at $8.9M in Q4 2022.
  • 45 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.